deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT04124367

IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE (IMPULSE)

IMPULSE StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE A Prospective, Multi-center, Randomized, Double-blind Study to Assess Efficacy and Safety of Neuroplastic Intervention by Cerebrolysin and atDCS on Motor Function Recovery in Subacute and Chronic Stroke Patients

Sponsor: Ever Neuro Pharma GmbH

Conditions Chronic Stroke Subacute Stroke
Interventions Cerebrolysin Placebo non-invasive brain stimulation sham intervention
Updated 10 times since 2019 Last updated: Jul 26, 2022 Started: Jun 25, 2021 Primary completion: Mar 21, 2022 Completion: Mar 21, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

for strategic and pandemic reasons

Other terminated trials from Ever Neuro Pharma GmbH

More terminations from Ever Neuro Pharma GmbH

This PHASE2 trial investigates Chronic Stroke and Subacute Stroke and is currently terminated or withdrawn. Ever Neuro Pharma GmbH leads this study, which shows 10 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Nov 2019 – ~Mar 2020 · 4 months · monthly snapshot~Mar 2020 – ~Jun 2020 · 3 months · monthly snapshot~Jun 2020 – ~Sep 2020 · 3 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Sep 2022 — Jul 2024 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  4. Sep 2021 — Sep 2022 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. May 2021 — Sep 2021 [monthly]

    Not Yet Recruiting PHASE2

▶ Show 5 earlier versions

  1. Jan 2021 — May 2021 [monthly]

    Not Yet Recruiting PHASE2

  2. Sep 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

  3. Jun 2020 — Sep 2020 [monthly]

    Not Yet Recruiting PHASE2

  4. Mar 2020 — Jun 2020 [monthly]

    Not Yet Recruiting PHASE2

  5. Nov 2019 — Mar 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ever Neuro Pharma GmbH
  • VASCage GmbH
Data source: Ever Neuro Pharma GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations